mhurhangee/ep-ind-claims huggingface dataset:
A system comprising: at least one power device including: an input to receive power from a power source; an output operatively coupled to the input and configured to provide power; a data storage; a network interface; and a controller coupled to the input, the output, the data storage and the network interface and configured to: provide, according to a reporting schedule, identification information directly to a cloud service via the network interface; provide, according to the reporting schedule, secured information directly to the cloud service, the secured information being descriptive of performance of the at least one power device; detect occurrence of an event of importance; assign, responsive to detecting that the event of importance has occurred, a value to the event of importance corresponding to a level of importance; compare the value to a threshold; and transmit, responsive to detecting that the event of importance has occurred and comparing the value to the threshold, event information directly to the cloud service, the event information being descriptive of the event of importance. an input to receive power from a power source; an output operatively coupled to the input and configured to provide power; a data storage; a network interface; and a controller coupled to the input, the output, the data storage and the network interface and configured to: provide, according to a reporting schedule, identification information directly to a cloud service via the network interface; provide, according to the reporting schedule, secured information directly to the cloud service, the secured information being descriptive of performance of the at least one power device; detect occurrence of an event of importance; assign, responsive to detecting that the event of importance has occurred, a value to the event of importance corresponding to a level of importance; compare the value to a threshold; and transmit, responsive to detecting that the event of importance has occurred and comparing the value to the threshold, event information directly to the cloud service, the event information being descriptive of the event of importance. provide, according to a reporting schedule, identification information directly to a cloud service via the network interface; provide, according to the reporting schedule, secured information directly to the cloud service, the secured information being descriptive of performance of the at least one power device; detect occurrence of an event of importance; assign, responsive to detecting that the event of importance has occurred, a value to the event of importance corresponding to a level of importance; compare the value to a threshold; and transmit, responsive to detecting that the event of importance has occurred and comparing the value to the threshold, event information directly to the cloud service, the event information being descriptive of the event of importance.
An antenna connection apparatus, configured to couple an antenna to a feed point or a ground point, and comprising: a solder pad, a first dielectric layer, a coupling metal layer, and a second dielectric layer that are stacked, the first dielectric layer being located between the solder pad and the coupling metal layer, the coupling metal layer being located between the first dielectric layer and the second dielectric layer, and the solder pad being electrically connected to the coupling metal layer by at least one via hole arranged in the first dielectric layer; a side of the solder pad facing away from the first dielectric layer being used for being electrically connected to the feed point or the ground point; and a side of the second dielectric layer facing away from the coupling metal layer for being connected to the antenna, to allow the antenna to be coupled to the coupling metal layer; wherein hardness of the second dielectric layer is less than hardness of the first dielectric layer; and wherein the second dielectric layer is an insulation layer made of a flexible material, and the first dielectric layer is an insulation layer made of an inflexible material. a solder pad, a first dielectric layer, a coupling metal layer, and a second dielectric layer that are stacked, the first dielectric layer being located between the solder pad and the coupling metal layer, the coupling metal layer being located between the first dielectric layer and the second dielectric layer, and the solder pad being electrically connected to the coupling metal layer by at least one via hole arranged in the first dielectric layer; a side of the solder pad facing away from the first dielectric layer being used for being electrically connected to the feed point or the ground point; and a side of the second dielectric layer facing away from the coupling metal layer for being connected to the antenna, to allow the antenna to be coupled to the coupling metal layer; wherein hardness of the second dielectric layer is less than hardness of the first dielectric layer; and wherein the second dielectric layer is an insulation layer made of a flexible material, and the first dielectric layer is an insulation layer made of an inflexible material.
A method for system diagnosis and status reporting, comprising: Receiving, by a processor unit, network traffic from an aircraft data network on an aircraft, wherein the network traffic is placed on the aircraft data network by a plurality of systems on the aircraft and wherein the plurality of systems perform a number of functions for the aircraft; Receiving, by the processor unit, a view selection, wherein the view selection identifies rules for determining a status of selected ones of the number of functions from the network traffic; responsive to receiving the view selection, determining, by the processor unit, the status of the selected ones of the number of functions from the network traffic using the rules; and providing, by the processor unit, the status of the selected ones of the number of functions to a user interface. Receiving, by a processor unit, network traffic from an aircraft data network on an aircraft, wherein the network traffic is placed on the aircraft data network by a plurality of systems on the aircraft and wherein the plurality of systems perform a number of functions for the aircraft; Receiving, by the processor unit, a view selection, wherein the view selection identifies rules for determining a status of selected ones of the number of functions from the network traffic; responsive to receiving the view selection, determining, by the processor unit, the status of the selected ones of the number of functions from the network traffic using the rules; and providing, by the processor unit, the status of the selected ones of the number of functions to a user interface.
A device for supporting a diagnosis of a cancer patient to be examined comprising: acquiring means for acquiring the specific activity of cyclin dependent kinase 1 (i.e. a first CDK parameter) of the cancer patient to be examined, and the specific activity of cyclin dependent kinase 2 (i.e. a second CDK parameter) of the cancer patient to be examined; a memory storing sample data from a plurality of sample cancer patients to whom anthracycline anticancer drugs have been administered, each of the sample data comprising: the first and second CDK parameter of the sample patient; and information regarding recurrence of the cancer of the sample patient; selecting means for selecting the sample data stored in the memory whose first CDK parameter and second CDK parameter are in a prescribed range, wherein the range contains the first CDK parameter and the second CDK parameter of the cancer patient to be examined; and display means for displaying the information regarding a cancer recurrence comprised in the selected sample data; and a controller, including said memory under control of a processor, and instructions enabling the processor to carry out operations comprising the aforementioned steps of acquiring, selecting and displaying. acquiring means for acquiring the specific activity of cyclin dependent kinase 1 (i.e. a first CDK parameter) of the cancer patient to be examined, and the specific activity of cyclin dependent kinase 2 (i.e. a second CDK parameter) of the cancer patient to be examined; a memory storing sample data from a plurality of sample cancer patients to whom anthracycline anticancer drugs have been administered, each of the sample data comprising: the first and second CDK parameter of the sample patient; and information regarding recurrence of the cancer of the sample patient; the first and second CDK parameter of the sample patient; and information regarding recurrence of the cancer of the sample patient; selecting means for selecting the sample data stored in the memory whose first CDK parameter and second CDK parameter are in a prescribed range, wherein the range contains the first CDK parameter and the second CDK parameter of the cancer patient to be examined; and display means for displaying the information regarding a cancer recurrence comprised in the selected sample data; and a controller, including said memory under control of a processor, and instructions enabling the processor to carry out operations comprising the aforementioned steps of acquiring, selecting and displaying.
Process for culturing microalgae strains of the genus Crypthecodinium having a gene encoding the small subunit 18s ribosomal RNA having a genetic similarity of at least 96% with the same gene of the strain of the species Crypthecodinium cohnii, deposited in the CCAP (Culture Collection of Algae and Protozoa) under number CCAP 1104/3, for the production of biomass with a density at least greater than 50 g/L dry matter, having a DHA content at least greater than 5 g/L in the culture, characterized in that it comprises at least a first step wherein said strains are cultivated in a chemically defined medium for a sufficient time to achieve a strain concentration between 5·10 6 and 5·10 8 cells/mL, said chemically defined medium comprising - as macroelements: sodium chloride (NaCl), magnesium chloride, sodium bicarbonate (NaHCO 3), potassium hydrogen phosphate (K 2 HPO 4), calcium chloride, iron chloride (FeCl 3 6H 2 O), boric acid (H 3 BO 3) and a nitrogen source - as microelements: disodium ethylenediaminetetraacetic acid (Na 2 EDTA), manganese chloride tetrahydrate (MnCl 2 4H 2 O), zinc chloride (ZnCl 2), cobalt chloride hexahydrate (CoCl 2 6H 2 O), copper sulfate pentahydrate (CuSO 4 5H 2 O), and nickel sulfate hexahydrate (NiSO 4 6H 2 O); - as vitamin: biotin, thiamine, cobalamin or vitamin B12 and pantothenate or vitamin B5, - and a carbon source, and at least a second step wherein one or more carbon source enrichment solution(s) comprising at the same time the carbon source, the nitrogen source and the phosphorus source (C/N/P enrichment solution) are added, simultaneously or successively, to the culture medium. - as macroelements: sodium chloride (NaCl), magnesium chloride, sodium bicarbonate (NaHCO 3), potassium hydrogen phosphate (K 2 HPO 4), calcium chloride, iron chloride (FeCl 3 6H 2 O), boric acid (H 3 BO 3) and a nitrogen source - as microelements: disodium ethylenediaminetetraacetic acid (Na 2 EDTA), manganese chloride tetrahydrate (MnCl 2 4H 2 O), zinc chloride (ZnCl 2), cobalt chloride hexahydrate (CoCl 2 6H 2 O), copper sulfate pentahydrate (CuSO 4 5H 2 O), and nickel sulfate hexahydrate (NiSO 4 6H 2 O); - as vitamin: biotin, thiamine, cobalamin or vitamin B12 and pantothenate or vitamin B5, - and a carbon source,
A modular unit for improving indoor air quality, comprising: a frame surrounding an open interior and defining the outer periphery of the unit, the frame including a pair of parallel spaced apart lateral members (34,36) connected by at least one tensioning cable (44,46) and at least one aperture in at least one of the lateral members opening into the open interior; air permeable, antimicrobial, morbidity-inducing fabric, comprising a naturally occurring antimicrobial botanical compound, secured about the frame periphery on a first side of the frame and covering the open interior on a first side of the frame; a fan housed in said aperture for blowing air from outside the frame into the frame interior for subsequent passage of air blown into the frame interior outwardly through the fabric, the frame periphery on a remaining side of the frame being adapted to fit against a wall; the cable(s) being adapted to connect to one or more cable gripping devices mounted in a wall so upon connection to the cable gripping devices the cable pulls the remaining side of the frame against the wall thereby closing the unit interior so that air may enter the unit interior only by action of the fan. a frame surrounding an open interior and defining the outer periphery of the unit, the frame including a pair of parallel spaced apart lateral members (34,36) connected by at least one tensioning cable (44,46) and at least one aperture in at least one of the lateral members opening into the open interior; air permeable, antimicrobial, morbidity-inducing fabric, comprising a naturally occurring antimicrobial botanical compound, secured about the frame periphery on a first side of the frame and covering the open interior on a first side of the frame; a fan housed in said aperture for blowing air from outside the frame into the frame interior for subsequent passage of air blown into the frame interior outwardly through the fabric, the frame periphery on a remaining side of the frame being adapted to fit against a wall; the cable(s) being adapted to connect to one or more cable gripping devices mounted in a wall so upon connection to the cable gripping devices the cable pulls the remaining side of the frame against the wall thereby closing the unit interior so that air may enter the unit interior only by action of the fan.
A vaccine composition comprising a pharmaceutically acceptable carrier or diluent and an isolated polypeptide chosen from: (a) an isolated polypeptide consisting of an amino acid sequence having at least 85% identity to the amino acid sequence set forth in SEQ ID NO:10; (b) an isolated polypeptide consisting of an amino acid sequence having at least 90% identity to the amino acid sequence set forth in SEQ ID NO:10; (c) an isolated polypeptide consisting of an amino acid sequence having at least 95% identity to the amino acid sequence set forth in SEQ ID NO:10; (d) an isolated polypeptide consisting of the amino acid sequence set forth in SEQ ID NO:10; (e) an isolated polypeptide that is an analog of a polypeptide consisting of the amino acid sequence of SEQ ID NO:10, wherein the analog has fewer than 20 substitutions or deletions of amino acid residues of SEQ ID NO:10; (f) an immunogenic fragment consisting of at least 15 contiguous amino acids from the amino acid sequence set forth in SEQ ID NO:10, wherein the immunogenic fragment can elicit an immune response to Haemophilus influenzae; (g) the isolated polypeptide of (a), (b), (c), (d), or (e), wherein the N-terminal Met residue is deleted; and (h) the isolated polypeptide of (a), (b), (c), (d), or (e), wherein the secretory amino acid sequence is deleted, wherein the isolated polypeptide can elicit an immune response to Haemophilus influenzae. (a) an isolated polypeptide consisting of an amino acid sequence having at least 85% identity to the amino acid sequence set forth in SEQ ID NO:10; (b) an isolated polypeptide consisting of an amino acid sequence having at least 90% identity to the amino acid sequence set forth in SEQ ID NO:10; (c) an isolated polypeptide consisting of an amino acid sequence having at least 95% identity to the amino acid sequence set forth in SEQ ID NO:10; (d) an isolated polypeptide consisting of the amino acid sequence set forth in SEQ ID NO:10; (e) an isolated polypeptide that is an analog of a polypeptide consisting of the amino acid sequence of SEQ ID NO:10, wherein the analog has fewer than 20 substitutions or deletions of amino acid residues of SEQ ID NO:10; (f) an immunogenic fragment consisting of at least 15 contiguous amino acids from the amino acid sequence set forth in SEQ ID NO:10, wherein the immunogenic fragment can elicit an immune response to Haemophilus influenzae; (g) the isolated polypeptide of (a), (b), (c), (d), or (e), wherein the N-terminal Met residue is deleted; and (h) the isolated polypeptide of (a), (b), (c), (d), or (e), wherein the secretory amino acid sequence is deleted,
A bearing assembly comprising: a case; a bearing spring positioned inside the case; a first seal positioned between the case and the bearing spring; and a second seal (64; 164; 264; 364) positioned between the case and the bearing spring and spaced apart from the first seal, wherein the second seal (64; 164; 264; 364) is an adjustable seal that is movable between a closed position and an opened position to inhibit or allow, respectively, a fluid to flow from a cavity that is defined by the case, the bearing spring, the first seal and the second seal (64; 164; 264; 364), characterised in that the second seal (64; 164; 264; 364) is a valve, the valve (64; 164; 264; 364) comprises a first annular ring (70; 170; 270; 370) and a second annular ring (72; 172; 272; 372), and the second annular ring (72; 172; 272; 372) is moveable relative to the first annular ring (70; 170; 270; 370). a case; a bearing spring positioned inside the case; a first seal positioned between the case and the bearing spring; and a second seal (64; 164; 264; 364) positioned between the case and the bearing spring and spaced apart from the first seal, wherein the second seal (64; 164; 264; 364) is an adjustable seal that is movable between a closed position and an opened position to inhibit or allow, respectively, a fluid to flow from a cavity that is defined by the case, the bearing spring, the first seal and the second seal (64; 164; 264; 364), characterised in that the second seal (64; 164; 264; 364) is a valve, the valve (64; 164; 264; 364) comprises a first annular ring (70; 170; 270; 370) and a second annular ring (72; 172; 272; 372), and the second annular ring (72; 172; 272; 372) is moveable relative to the first annular ring (70; 170; 270; 370).
A drug delivery device (50, 700) comprising: a body that comprises a wall (64, 82) bounding a reservoir defined within the body, the wall having at least one preformed through-hole disposed therein and comprising a water-permeable portion, the body comprising an elastic portion; and a drug formulation which comprises a drug, the drug formulation being disposed within the reservoir; wherein the drug delivery device comprises at least one restraining plug closing off an opening of the body and contacting the elastic portion of the body, the opening being in fluid communication with the reservoir, wherein the water-permeable portion of the wall is configured to permit water to enter the drug delivery device and contact the drug formulation located in the reservoir, characterized in that release of the drug from the device is controlled by (i) release of the drug through the at least one preformed through-hole in the wall, and (ii) release of the drug through the transient formation of one or more microchannels between the elastic portion of the body and the at least one restraining plug, extending to the opening, upon the generation within the reservoir of a hydrostatic pressure effective to form the one or more microchannels. a body that comprises a wall (64, 82) bounding a reservoir defined within the body, the wall having at least one preformed through-hole disposed therein and comprising a water-permeable portion, the body comprising an elastic portion; and a drug formulation which comprises a drug, the drug formulation being disposed within the reservoir; wherein the drug delivery device comprises at least one restraining plug closing off an opening of the body and contacting the elastic portion of the body, the opening being in fluid communication with the reservoir, wherein the water-permeable portion of the wall is configured to permit water to enter the drug delivery device and contact the drug formulation located in the reservoir, characterized in that release of the drug from the device is controlled by (i) release of the drug through the at least one preformed through-hole in the wall, and (ii) release of the drug through the transient formation of one or more microchannels between the elastic portion of the body and the at least one restraining plug, extending to the opening, upon the generation within the reservoir of a hydrostatic pressure effective to form the one or more microchannels.
A clutch device for a gas turbine engine having a gearbox and a rotational output shaft, the clutch device comprising: a sliding coupling mounted to the engine and slidingly displaceable therein, the sliding coupling being mountable between the gearbox and the output shaft, the sliding coupling being continuously engageable with the gearbox and being selectively engageable with the output shaft to mechanically couple the output shaft to the gearbox, the sliding coupling being slidingly displaceable between a first position in which the sliding coupling is mechanically coupled to the output shaft to transmit a rotational drive of the output shaft to the gearbox, and a second position in which the sliding coupling is disengaged from the output shaft; and a piston disposed within the engine and acting on the sliding coupling to displace the sliding coupling to at least the second position. a sliding coupling mounted to the engine and slidingly displaceable therein, the sliding coupling being mountable between the gearbox and the output shaft, the sliding coupling being continuously engageable with the gearbox and being selectively engageable with the output shaft to mechanically couple the output shaft to the gearbox, the sliding coupling being slidingly displaceable between a first position in which the sliding coupling is mechanically coupled to the output shaft to transmit a rotational drive of the output shaft to the gearbox, and a second position in which the sliding coupling is disengaged from the output shaft; and a piston disposed within the engine and acting on the sliding coupling to displace the sliding coupling to at least the second position.